Healthy Older AdultsNCT07327541
Cognitive, Physical, and Pain-Related Correlates in Community-Dwelling Older Adults
An observational study of Healthy Older Adults, run by Sahmyook University at 1 site in South Korea.
Trial summary
This study aims to evaluate the cognitive function, physical function, and pain levels of community-dwelling older adults to determine the impact of cognitive ability on physical function and pain. It also seeks to establish foundational data for strategies to prevent dementia and sarcopenia. Read more about this study
- Who is it for?
- Ages 65 years and olderHealthy volunteers can take part
- Conditions the study is for
- Healthy Older Adults
- How many people
- 130 participants
- Where
- 1 siteSouth Korea
- Study dates
- 12 Jan 2026to 13 Apr 2026
- How long will I take part?
- 1 Day
- Phase
- Observational
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 65 years and older
- All sexes
- Healthy volunteers accepted
- Older adult
Study population: Participants in this study will consist of community-dwelling adults aged 65 years or older who use local senior welfare centers and voluntarily agree to participate in the research.
Who may be able to join
- Community-dwelling adults aged 65 years or older who are able to walk independently
Who cannot join
- Individuals with severe cognitive impairment that makes test participation difficult (e.g., diagnosed dementia)
- Individuals with acute neurological injury within the past 6 months (e.g., stroke)
- Individuals for whom gait testing is not feasible for safety reasons
Trial locations and contacts
1 site in 1 country.
About this study
Official title: Correlations Among Cognitive Function, Physical Function, and Pain Indicators in Community-Dwelling Older Adults: A Cross-Sectional Study
This study aims to evaluate the cognitive function, physical function, and pain levels of community-dwelling older adults to determine the impact of cognitive ability on physical function and pain. It also seeks to establish foundational data for strategies to prevent dementia and sarcopenia.
Therefore, the purpose of this study is to measure the cognitive function (overall cognition, executive function, memory, attention, etc.), physical function (muscle mass, muscle strength, gait and balance ability), and pain of community-dwelling older adults, and to analyze the correlations between these factors.
- Conditions
- Healthy Older Adults
What is being measured
The primary outcome is the main question the study is designed to answer.
Overall cognitive function: MoCA-K
Cognitive function will be assessed using the MoCA-K.
Measured: From enrollment to the end of evaluation within 1weeks
Skeletal Muscle Mass Index
The skeletal muscle mass index is the sum of limb muscle mass divided by the square of height (kg/m²).
Measured: From enrollment to the end of evaluation within 1weeks
Grip strength
Grip strength will be measured using a dynamometer. The subject will sit in a chair with arms extended, elbows bent at 90 degrees, forearms at a natural angle, and wrists in a dorsal flexion position between 0 and 30 degrees. The subject will grip the dynamometer for 3 seconds, and the average value (kg) will be recorded after 3 attempts.
Measured: From enrollment to the end of evaluation within 1weeks.
Lower Limb Strength
5 Sit-to-Stand (5xSST) measures the time (seconds) it takes for the subject to transition from a seated position to a standing position and back to a seated position five times. A shorter time indicates better muscle strength. The subject is instructed to cross their arms over their chest, avoid leaning their back or legs against the chair, and perform the sit-to-stand motion five times as quickly as possible.
Measured: From enrollment to the end of evaluation within 1weeks.
Level of musculoskeletal pain
For participants with musculoskeletal pain, the level of pain will be assessed using the Numeric Pain Rating Scale (NPRS), where 10 indicates the most severe pain and 0 indicates no pain.
Measured: From enrollment to the end of evaluation within 1weeks.
Secondary outcomes (7)
The Word Memory Test
The Word List Memory Test, Word List Recall Test, and Word List Recognition Test of the CERAD-K consist of cards printed with 10 high-frequency, high-imagery words. Participants are instructed to read the words aloud to become familiar with them and to maintain attention. For participants who are illiterate, the examiner reads the words aloud and instructs them to repeat them. After presenting the 10 words at a consistent pace, participants are asked to recall as many words as possible.
Measured: From enrollment to the end of evaluation within 1weeks.
Executive function and attention
Executive function and attention will be assessed using the Trail Making Test Parts A / B.
Measured: From enrollment to the end of evaluation within 1weeks.
Executive function
Executive function will be assessed using the Stroop world color Test.
Measured: From enrollment to the end of evaluation within 1weeks.
Subjective Cognitive Decline
The Subjective Memory Complaints Questionnaire (SMCQ), developed by Youn et al. (2009), consists of 14 items assessing individuals' subjective experiences of everyday memory difficulties.
Measured: From enrollment to the end of evaluation within 1weeks.
Static Balance in Three Positions
Static balance will be assessed using the Balancia program with the Wii Balance Board. Center of pressure variables, including path length and path sway, will be measured for 30 seconds each under eyes-open and eyes-closed conditions.
Static balance will be assessed under three conditions: normal stance, semi-tandem stance, and tandem stance.
Measured: From enrollment to the end of evaluation within 1weeks.
Dynamic Balance
Dynamic balance will be evaluated using the Timed Up and Go (TUG) test, in which the total time (in seconds) is recorded. Participants are instructed to sit in a chair with a backrest and, upon hearing the verbal cue "start," stand up, walk 3 meters at their usual walking speed, turn around, return to the chair, and sit down.
Measured: From enrollment to the end of evaluation within 1weeks.
Spatio-temporal gait variables
Gait analysis will be performed using the GAITRite walkway system. Participants will be instructed to walk across the mat at a comfortable, natural speed while wearing their usual footwear. Gait will be measured at least three times, and the mean values will be used for analysis. Key spatiotemporal variables will include gait velocity (cm/s), cadence (steps/min), step length (cm), stride length (cm), and step width (cm), as well as step length variability (%) and double support time (%).
Measured: From enrollment to the end of evaluation within 1weeks.
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted8 Jan 2026
- Study start12 Jan 2026
- Primary completion12 Mar 2026
- Study completion13 Apr 2026
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Healthy Older AdultsStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Other
- Time perspective
- Cross-sectional
- Enrolment
- 130 participants (actual)
- Target duration
- 1 Day
Sponsor and investigators
- Lead sponsor
- Sahmyook University
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Jihye Jung, Sahmyook University
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07327541
- Sponsor's protocol ID
- SYU IRB 2025-09-004-002
- Status last verified
- Nov 2025
- First submitted
- 1 Dec 2025
- Last updated
- 15 Apr 2026
- Results posted
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
Study at a glance
From the registry record, last updated by the sponsor on 15 Apr 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Correlations Among Cognitive Function, Physical Function, and Pain Indicators in Community-Dwelling Older Adults: A Cross-Sectional Study
- ClinicalTrials.gov ID
- NCT07327541
- Acronym / sponsor ID
- SYU IRB 2025-09-004-002
- Conditions
- Healthy Older Adults
- Study type
- Observational
- Recruitment status
- Completed
- Enrolment
- 130 participants (actual)
- Lead sponsor
- Sahmyook UniversityUniversity, hospital or other
- Study start
- 12 Jan 2026 (actual)
- Primary completion
- 12 Mar 2026 (actual)
- Study completion
- 13 Apr 2026 (actual)
- First posted
- 8 Jan 2026 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
This study aims to evaluate the cognitive function, physical function, and pain levels of community-dwelling older adults to determine the impact of cognitive ability on physical function and pain. It also seeks to establish foundational data for strategies to prevent dementia and sarcopenia.
Therefore, the purpose of this study is to measure the cognitive function (overall cognition, executive function, memory, attention, etc.), physical function (muscle mass, muscle strength, gait and balance ability), and pain of community-dwelling older adults, and to analyze the correlations between these factors.
Study design
- Observational model
- Other
- Time perspective
- Cross-sectional
- Target follow-up
- 1 Day
Who may qualify
- Ages
- 65 years and older
- Sex
- All
- Healthy volunteers
- Accepted
- Age groups
- Older adult
- Study population
- Participants in this study will consist of community-dwelling adults aged 65 years or older who use local senior welfare centers and voluntarily agree to participate in the research.
Key inclusion criteria (1 listed)
- Community-dwelling adults aged 65 years or older who are able to walk independently
Key exclusion criteria (3 listed)
- Individuals with severe cognitive impairment that makes test participation difficult (e.g., diagnosed dementia)
- Individuals with acute neurological injury within the past 6 months (e.g., stroke)
- Individuals for whom gait testing is not feasible for safety reasons
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Primary outcome
Overall cognitive function: MoCA-K
Time frame: From enrollment to the end of evaluation within 1weeks
Cognitive function will be assessed using the MoCA-K.
Skeletal Muscle Mass Index
Time frame: From enrollment to the end of evaluation within 1weeks
The skeletal muscle mass index is the sum of limb muscle mass divided by the square of height (kg/m²).
Grip strength
Time frame: From enrollment to the end of evaluation within 1weeks.
Grip strength will be measured using a dynamometer. The subject will sit in a chair with arms extended, elbows bent at 90 degrees, forearms at a natural angle, and wrists in a dorsal flexion position between 0 and 30 degrees. The subject will grip the dynamometer for 3 seconds, and the average value (kg) will be recorded after 3 attempts.
Lower Limb Strength
Time frame: From enrollment to the end of evaluation within 1weeks.
5 Sit-to-Stand (5xSST) measures the time (seconds) it takes for the subject to transition from a seated position to a standing position and back to a seated position five times. A shorter time indicates better muscle strength. The subject is instructed to cross their arms over their chest, avoid leaning their back or legs against the chair, and perform the sit-to-stand motion five times as quickly as possible.
Level of musculoskeletal pain
Time frame: From enrollment to the end of evaluation within 1weeks.
For participants with musculoskeletal pain, the level of pain will be assessed using the Numeric Pain Rating Scale (NPRS), where 10 indicates the most severe pain and 0 indicates no pain.
7 secondary outcomes
The Word Memory Test
Time frame: From enrollment to the end of evaluation within 1weeks.
Executive function and attention
Time frame: From enrollment to the end of evaluation within 1weeks.
Executive function
Time frame: From enrollment to the end of evaluation within 1weeks.
Subjective Cognitive Decline
Time frame: From enrollment to the end of evaluation within 1weeks.
Static Balance in Three Positions
Time frame: From enrollment to the end of evaluation within 1weeks.
Dynamic Balance
Time frame: From enrollment to the end of evaluation within 1weeks.
Spatio-temporal gait variables
Time frame: From enrollment to the end of evaluation within 1weeks.
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 15 Apr 2026.
Related trials for Healthy Older Adults
Recruiting
Colon-delivered Riboflavin and Gut Microbiota Composition
Microbiome Dysbiosis, Gut Health
RecruitingPhase 1
Effects of Trigonelline Monohydrate on NAD+ Metabolism, Pharmacokinetics, Safety, and Tolerability in Healthy Adults
NAD+ Metabolism, Pharmacokinetics
RecruitingPhase 1/2
Clinical Trial of Recombinant Herpes Zoster Vaccine (ZFA01 Adjuvant, CHO Cells)
Herpes Zoster
Recruiting
Effects of Breathing Exercises on Cognition in Older Adults
Older Adults (65 Years and Older), Cognition
Not yet recruiting
Stearic Acid and Endothelial Function
Healthy Middle-aged Subjects, Obesity & Overweight
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
The record lists no contact. Use the official record to reach the sponsor.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Healthy Older Adults, run by Sahmyook University at 1 site in South Korea.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 1 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 15 Apr 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in South Korea. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Overall cognitive function: MoCA-K (time frame: From enrollment to the end of evaluation within 1weeks). The study lists 5 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 15 Apr 2026.